Work

Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial

Year: 2013

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Lara D. Veeken

DOI: 10.1093/rheumatology/kes381

Authors: Mittie K. Doyle, Mahboob U. Rahman, Bart Frederick, Charles A. Birbara, Dick de Vries, Gary Toedter, Xiaoying Wu, Dion Chen, Veena K. Ranganath, Mark E. Westerman, Daniel E. Furst

Institutions: Janssen Research & Development (United States), University of Pennsylvania, University of California, Los Angeles

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Genentech

OpenAlex ID: W2120116963

FWCI: 3.828

Cites: 25

Cited by: 40

Related to: 10